NOVN.CH

91.26

+1.16%↑

NOVN.CH

91.26

+1.16%↑

NOVN.CH

91.26

+1.16%↑

NOVN.CH

91.26

+1.16%↑

NOVN.CH

91.26

+1.16%↑

Search

Roche Holding AG

Closed

SectorHealthcare

273.6 0.51

Overview

Share price change

24h

Current

Min

269

Max

277

Key metrics

By Trading Economics

Income

-4.2B

2B

Sales

-109M

31B

P/E

Sector Avg

26.88

56.602

Dividend yield

3.5

Profit margin

6.588

Employees

103,249

EBITDA

-4.6B

6B

Dividends

By Dow Jones

Dividend yield

Sector Avg

3.50%

2.45%

Market Stats

By TradingEconomics

Market Cap

-8.9B

210B

Previous open

273.09

Previous close

273.6

News Sentiment

By Acuity

29%

71%

73 / 382 Ranking in Healthcare

Roche Holding AG Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 maj 2025, 02:16 UTC

Major Market Movers

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

24 kwi 2025, 07:30 UTC

Earnings

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24 kwi 2025, 05:31 UTC

Earnings

Roche Sales Rise Boosted By Key Drugs

9 kwi 2025, 09:39 UTC

Major Market Movers

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

12 mar 2025, 09:23 UTC

Major Market Movers

Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche

30 sty 2025, 09:36 UTC

Earnings

Roche Expects Growth to Continue This Year After Sales, Earnings Beat Forecasts -- Update

30 sty 2025, 06:32 UTC

Earnings

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

2 maj 2025, 06:25 UTC

Market Talk
Earnings

Roche Shows Pipeline Progress But Near-Term Risks Remain -- Market Talk

24 kwi 2025, 09:39 UTC

Market Talk
Earnings

Roche's Pipeline in Focus After Solid Results -- Market Talk

24 kwi 2025, 09:24 UTC

Market Talk
Earnings

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24 kwi 2025, 09:18 UTC

Market Talk
Earnings

Roche's Results Are Solid -- Market Talk

24 kwi 2025, 05:16 UTC

Top News

Roche Sales Rise, Boosted By Key Drugs

22 kwi 2025, 10:51 UTC

Top News

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15 kwi 2025, 09:55 UTC

Market Talk

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9 kwi 2025, 10:03 UTC

Market Talk
Earnings

Roche's Eye Drug in Focus for 1Q Earnings -- Market Talk

9 kwi 2025, 07:23 UTC

Market Talk

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

3 kwi 2025, 08:41 UTC

Market Talk

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

3 kwi 2025, 07:51 UTC

Market Talk

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

31 mar 2025, 09:31 UTC

Hot Stocks

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

13 mar 2025, 07:46 UTC

Market Talk

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

12 mar 2025, 16:34 UTC

Top News

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal -- Update

12 mar 2025, 08:51 UTC

Market Talk

Roche's Multiple-Sclerosis Drug Sales Potential Fuels Rating Upgrade -- Market Talk

12 mar 2025, 08:18 UTC

Market Talk

Roche's Obesity Deal With Zealand Pharma Makes Sense, Vontobel Says -- Market Talk

13 lut 2025, 11:43 UTC

Market Talk

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

30 sty 2025, 07:56 UTC

Market Talk
Earnings

Roche Delivered Solid Results But Diagnostics' Profitability Disappoints -- Market Talk

30 sty 2025, 06:04 UTC

Earnings

Roche Expects 2025 EPS Growth in High Single Digit Range at Constant Currency

30 sty 2025, 06:04 UTC

Earnings

Roche Expects 2025 Sales Increase in Mid Single Digit Range at Constant Currency

30 sty 2025, 06:04 UTC

Earnings

Roche Issues 2025 View

30 sty 2025, 06:03 UTC

Earnings

Roche Raises Dividend to CHF9.70 Vs CHF9.60

30 sty 2025, 06:03 UTC

Earnings

Roche 2024 Core Operating Profit CHF20.82B

Peer Comparison

Price change

Roche Holding AG Forecast

Sentiment

By Acuity

73 / 382 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.